Ana Alfonso

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Integrated Single-Cell and Spatial Multi-Omics of Clonal Precursors and Immune Niches in Germinal Center Lymphomas.

Integrated Single-Cell and Spatial Multi-Omics of Clonal Precursors and Immune Niches in Germinal Center Lymphomas.

Journal: Cancers

Published: March 05, 2026

Enasidenib as treatment for AML with IDH2 mutation: multicenter real-life study of the early-access program in Spain.

Enasidenib as treatment for AML with IDH2 mutation: multicenter real-life study of the early-access program in Spain.

Journal: Annals of hematology

Published: April 09, 2025

Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia.

Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia.

Journal: Blood advances

Published: March 20, 2024

Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.

Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia.

Journal: Frontiers in immunology

Published: August 01, 2023

Severe laryngeal edema after CAR-T cell treatment in a patient with multiple myeloma: A case report.

Severe laryngeal edema after CAR-T cell treatment in a patient with multiple myeloma: A case report.

Journal: Clinical case reports

Published: December 22, 2022

11C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to 18F-FDG PET/CT and Prognostic Value.

11C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to 18F-FDG PET/CT and Prognostic Value.

Journal: International journal of molecular sciences

Published: July 06, 2022

Prognostic impact of micromegakaryocytes in primary myelodysplastic syndromes.

Prognostic impact of micromegakaryocytes in primary myelodysplastic syndromes.

Journal: Leukemia & lymphoma

Published: December 31, 2021

CAR T-Cells in Multiple Myeloma Are Ready for Prime Time.

CAR T-Cells in Multiple Myeloma Are Ready for Prime Time.

Journal: Journal of clinical medicine

Published: October 14, 2020

Differences in Venous Thromboembolism Prevention and Outcome between Hospitalized Patients with Solid and Hematologic Malignancies.

Differences in Venous Thromboembolism Prevention and Outcome between Hospitalized Patients with Solid and Hematologic Malignancies.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: March 07, 2019

Improvement of appropriate pharmacological prophylaxis in hospitalised cancer patients with a multiscreen e-alert system: a single-centre experience.

Improvement of appropriate pharmacological prophylaxis in hospitalised cancer patients with a multiscreen e-alert system: a single-centre experience.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: September 10, 2018

Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study.

Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study.

Journal: PloS one

Published: March 25, 2018

First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study.

First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study.

Journal: European journal of haematology

Published: May 24, 2016

Showing 1-12 of 21

Last Updated: 09/26/2026